# Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

Study · id `cardio:ct-nct07275697` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07275697](<https://clinicaltrials.gov/study/NCT07275697>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07275697

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07275697. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2028-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07275697, source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)
- Started: 2026-03-23 (actual) (ClinicalTrials.gov record NCT07275697, source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)
- Primary completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT07275697, source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)
- Completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT07275697, source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT07275697, source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07275697-2026-08-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- Acronym: WAIT
- Condition: Atrial Fibrillation (AF)
- Condition: Obesity & Overweight
- Intervention (Drug): Semaglutide 2.4 mg
- Intervention (Behavioral): Standard medical treatment
- Lead sponsor: Emma Svennberg
- Lead sponsor class: OTHER
- Collaborator: Karolinska Institutet
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Semaglutide (`cardio:semaglutide`)
- Registry intervention is a member of this class by a sourced record link: GLP-1 receptor agonists (drug class) (`cardio:glp1-receptor-agonists`)
- Registry lists this organization as a collaborator: Karolinska Institutet (`cardio:org-karolinska-institutet`)

## Provenance

Content hash: 827053bb32afb80e743a24f19bc1469d31b31dc58a943afdc1cc28a372ef7451
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
